Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations
- DOI
- 10.3390/cancers15225326
- Published
- 2023-11-08
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers15225326,
title = {Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations},
author = {Petros Christopoulos and Nicolas Girard and Claudia Proto and Marta Soares and Pilar Garrido Lopez and Anthonie J. van der Wekken and Sanjay Popat and Joris Diels and Claudio A. Schioppa and Jan Sermon and Nora Rahhali and Corinna Pick-Lauer and Agnieszka Adamczyk and James Penton and Marie Wislez},
year = {2023},
journal = {Cancers},
doi = {10.3390/cancers15225326},
url = {https://doi.org/10.3390/cancers15225326}
}RIS
TY - JOUR TI - Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations AU - Petros Christopoulos AU - Nicolas Girard AU - Claudia Proto AU - Marta Soares AU - Pilar Garrido Lopez AU - Anthonie J. van der Wekken AU - Sanjay Popat AU - Joris Diels AU - Claudio A. Schioppa AU - Jan Sermon AU - Nora Rahhali AU - Corinna Pick-Lauer AU - Agnieszka Adamczyk AU - James Penton AU - Marie Wislez PY - 2023 JO - Cancers DO - 10.3390/cancers15225326 UR - https://doi.org/10.3390/cancers15225326 ER -
APA
Christopoulos, P., Girard, N., Proto, C., Soares, M., Lopez, P. G., Wekken, A. J. V. D., Popat, S., Diels, J., Schioppa, C. A., Sermon, J., Rahhali, N., Pick-Lauer, C., Adamczyk, A., Penton, J., & Wislez, M. (2023). Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations. Cancers. https://doi.org/10.3390/cancers15225326
Source records
- crossref · retrieved 2026-09-24T23:47:40.998Z